Related Experiment Video
Updated: Apr 3, 2026
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Multidisciplinary approach to calcific uremic arteriolopathy
1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Insights
Calcific uremic arteriolopathy (CUA), or calciphylaxis, is a rare disease affecting dialysis patients. A multidisciplinary approach is key for managing CUA, though its exact cause and effective treatments require further research.
Area of Science:
- Nephrology
- Dermatology
- Vascular Medicine
Background:
- Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a rare and poorly understood condition.
- It predominantly affects patients with end-stage renal disease (ESRD).
Purpose of the Study:
- To describe the recent literature on CUA, including its limitations.
- To summarize a collaborative, multidisciplinary approach for CUA treatment and prevention.
Main Methods:
- Review of current scientific literature, primarily case reports and series.
- Analysis of recent findings on CUA incidence, risk factors, and management strategies.
Main Results:
- CUA literature is limited, but incidence may be increasing.
- Associations noted with vitamin K antagonists, obesity, and diabetes mellitus.
- Treatment strategies involve wound/pain management, sodium thiosulfate, mineral bone optimization, bisphosphonates, and risk factor avoidance.
Conclusions:
- A multidisciplinary and multimodal approach is advocated for CUA management.
- Further research is needed to clarify the efficacy of treatments like sodium thiosulfate.
Purpose Of Review:
Calcific uremic arteriolopathy (CUA), as known as calciphylaxis, is a rare and poorly understood disease seen predominantly in end stage renal disease patients. A collaborative multidisciplinary approach to develop and implement treatment and prevention methods is described.
Recent Findings:
Overall, the scientific literature on CUA is largely restricted to case reports and case series. Recent reports indicate that the incidence of CUA may be on the rise and emphasize an association with vitamin K antagonist therapy, obesity, and diabetes mellitus. Serum calcium, phosphorous, and parathyroid hormone levels have been reported to be quite variable in patients with CUA and may reflect the heterogeneity of study designs. A multidisciplinary and multimodal approach that incorporates wound and pain management, sodium thiosulfate, optimization of mineral bone parameters, bisphosphonates, and avoidance of risk factors such as vitamin K antagonist has been advocated in the latest reports. Sodium thiosulfate although used frequently to treat CUA has unclear efficacy requiring further examination.
Summary:
This review describes the recent literature in the field of CUA including its limitations. It provides a summary of a multidisciplinary approach to CUA management.
Related Concept Videos
01:30Urinary Tract Calculi III: Medical Management
01:28Chronic Kidney Disease III: Interprofessional Care
01:28Urinary Tract Calculi V: Nursing Management
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
01:27Peripheral Artery Disease III: Interprofessional Care
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations